Who makes Equinacea Arkopharma?

Equinacea Arkopharma is developed by Jesús R. Requena.

What development phase is Equinacea Arkopharma in?

Equinacea Arkopharma is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Equinacea Arkopharma

Jesús R. Requena · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Equinacea Arkopharma
Also known as	Echynacea hard caplets
Sponsor	Jesús R. Requena
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Echinacea Drug for Covid-19 (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Equinacea Arkopharma CI brief — competitive landscape report
Equinacea Arkopharma updates RSS · CI watch RSS
Jesús R. Requena portfolio CI